Chronic Migraine clinical trials
15 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Determining the Utility of a Behavioral Intervention in Chronic Migraine
- A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
- A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
- A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Acceptance and Commitment Therapy to Improve Disability in Chronic Migraine
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
- Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)
- BOTOX® vs. XEOMIN® for Chronic Migraine
- Topical Intranasal Anesthetic Block for Reducing the Pain of Botulinum Toxin Injections for Chronic Migraine
- Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
- Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics
- Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial
- A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine
- App-based Breathing Program for Migraine Relief
- Utilization of 60-Day Peripheral Nerve Stimulation of the Occipital Nerves for the Treatment of Headache
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Chronic Migraine” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.